Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Omental Adipose Removal Decreases High Blood Pressure in Hypertensive Patients Independent of Body Mass Index

The First Affiliated Hospital of Nanjing Medical Universtiyy, Nanjing, China

Title: Omental Adipose Removal Decreases High Blood Pressure in Hypertensive Patients Independent of Body Mass Index

Biography

Biography: Omental Adipose Removal Decreases High Blood Pressure in Hypertensive Patients Independent of Body Mass Index

Abstract

Omental adipose removal decreases high blood pressure in hypertensive patients independent of body mass index: It is a multicenter, prospective cohort clinical study. 133 patients with gastric or gynecological cancer were divided into 3 groups: non-hypertensive and omentum removed (NH&OR), hypertensive and omentum removed (H&OR), and hypertensive and omentum present (H&OP). The patients were followed up in sitting blood pressure (SBP), changes in related body mass index and metabolic indices. The time points of the 2 follow-up visits were 1 month ± 7 days after the operation before the start of chemotherapy and the endpoint of 8 ± 1 month. H&OR group showed significant reductions in SSBP and SDBP at 1-m (-16.94/-10.50 mmHg, both P < 0.001) and 8-m endpoint (-16.00/-5.50 mmHg, P < 0.001 and P = 0.004). Little reductions were observed with BMI of patients in 3 groups (H&OR group: 24.60 kg/m2 to 23.57 kg/m2, NH&OR group: 23.45 kg/m2 to 23.25 kg/m2, H&OP group: 25.74 kg/m2 to 25.24 kg/m2, all P > 0.05). No correlation was found between baseline BMI and 8-m change of SSBP and SDBP in H&OR groups. In both groups, triglyceride levels were significantly increased at 1-m after surgery (NH&OR 0.32 mmol/L, P = 0.006; H&OR 0.40 mmol/L, P = 0.010). Resection of omental adipose tissue represents an impact for reducing SSBP and SDBP at 8 months in hypertensive patients, even in the non-obese hypertensive population.